Search Within

Howard Scher

Formats
  1. Journal Article (624)
  2. Meeting Abstract (463)
  3. Book Section (13)
  4. Conference Paper (11)
  5. Editorial (6)
  6. Review (6)
  7. Guidelines (3)
  8. Correspondence (2)
  9. Research Letter (2)
Groups
  1. Department of Medicine (1130)
  2. Genitourinary Oncology Service (1130)
  3. Solid Tumor Oncology Division (1130)
  4. GSK Faculty (305)
  5. Sloan Kettering Institute Faculty (249)
  6. Molecular Pharmacology and Chemistry Program Faculty (229)

More Groups

People
  1. Michael Morris (217)
  2. Susan Slovin (140)
  3. Dana Rathkopf (133)
  4. Daniel Danila (111)
  5. Steven Larson (110)
  6. Victor Reuter (97)

More People

Years
  1. 2025 (8)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (25)
  5. 2021 (19)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (328)
  2. Clinical Cancer Research (85)
  3. Cancer Research (54)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (47)
  5. Journal of Urology (36)
  6. European Urology (35)

More Publications

Publishers
  1. American Society of Clinical Oncology (335)
  2. American Association for Cancer Research (197)
  3. Elsevier Science, Inc. (119)
  4. Elsevier Inc. (72)
  5. Nature Publishing Group (58)
  6. Oxford University Press (47)

More Publishers

Results (1130)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alterations of cell cycle regulators in Bilharzial-related bladder cancers
    Meeting Abstract

    Osman, I.; Pellicer, I.; Scher, H.; Zhang, Z. F.; Hamza, R.; Issa, S.; Khaled, H.; Cordon-Cardo, C.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Evaluation of the Hybritech free (PSA-f) and total PSA (PSA-t)
    Meeting Abstract

    Schwartz, M. K.; Smith, C.; Schwartz, D.; Dnistrian, A.; Fair, W.; Fleshner, N.; Scher, H.
    Clinical Chemistry (1996)

    Fulltext@MSK | Save
  • Telomerase activity repression during induced differentiation of human tumor cell lines
    Meeting Abstract

    Albanell, J.; Han, W.; Mellado, B.; Gunawardane, R.; Scher, H. I.; Dmitrovsky, E.; Moore, M. A. S.
    Abstracts of Papers of the American Chemical Society (1996)

    Fulltext@MSK | Save
  • Prostate cancer: Clinical considerations
    Book Section

    Hoffman, A.; Scher, H. I.
    In Luciani, L.; Debruyne, F. M. J.; Schalken, J. A. (Eds.) Basic Research in Urological Oncology (1996)

    Fulltext@MSK | Save
  • A dedication to Alan Yagoda, MD
    Journal Article

    Scher, H. I.
    Seminars in Oncology (1996)

    Fulltext@MSK | Save
  • Editorial comment
    Journal Article

    Scher, H. I.
    Journal of Urology (1996)

    Fulltext@MSK | Save
  • Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer
    Journal Article

    Donat, S. M.; Herr, H. W.; Bajorin, D. F.; Fair, W. R.; Sogani, P. C.; Russo, P.; Sheinfeld, J.; Scher, H. I.
    Journal of Urology (1996)

    Fulltext@MSK | Save
  • Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer
    Conference Paper

    Kelly, W. K.; Slovin, S.; Scher, H. I.
    Elsevier Inc. (1996)

    Fulltext@MSK | Save
  • Targeted therapy for prostate cancer: The Memorial Sloan-Kettering Cancer Center approach
    Conference Paper

    Slovin, S. F.; Livingston, P. O.; Rosen, N.; Sepp-Lorenzino, L.; Kelly, W. K.; Mendelsohn, J.; Scher, H. I.
    Elsevier Inc. (1996)

    Fulltext@MSK | Save
  • Detection of bony metastases of androgen-independent prostate cancer by PET-FDG
    Conference Paper

    Yeh, S. D. J.; Imbriaco, M.; Larson, S. M.; Garza, D.; Zhang, J. J.; Kalaigian, H.; Finn, R. D.; Reddy, D.; Horowitz, S. M.; Goldsmith, S. J.; more...
    Elsevier Science Inc. (1996)

    Fulltext@MSK | Save